7th ASM Conference on Candida and Candidiasis

第七届 ASM 念珠菌和念珠菌病会议

基本信息

项目摘要

DESCRIPTION (provided by applicant): Candida albicans is a commensal that colonizes skin and mucosal surfaces. It is also an agent of opportunistic disease of these surfaces as well as internal disseminated disease. While infections of cutaneous and mucosal surfaces may be a cause of significant morbidity and affect millions of Americans annually, they are not life threatening as is disseminated disease. In the mid-1980's a growing number of researchers were attracted to the study of pathogenesis of disease. In response to the need for exchange of ideas among this group, the first ASM Conference on Candida and Candidiasis was held in 1987 with an attendance of about 115. Since this time not only have the number of researchers grown but so have the number of patients with disease. Oral mucosal disease is unfortunately a nearly universal complication of AIDS and Candida has now become the fourth leading cause of nosocomial blood stream infections. In recent years there has been an emergence of azole resistant strains and increased frequency of non-albicans isolates, particularly those that are inherently drug resistant. This conference has been held every three years and is the premier forum for researchers engaged in study of the biology, epidemiology, and pathogenesis of candidal infection. However, at the 6th Conference in 2002 a large majority voted that the meeting by placed on a two-year schedule. Accordingly, the 7th Conference will be held March 24-28, 2004 at the Hyatt Regency in Austin, Texas. The goal of the 7th Conference is to continue to provide the forum to present the state of the art research and for investigators to meet and discuss their work informally. This 7th Conference is expected to have an attendance of 300 - 400 and the presentation of 150-200 posters. The topics that will be covered in the oral and/or poster sessions include: 1) mating and genetics, 2) epidemiology and population studies, 3) signaling and morphogenesis, 4) biofilms and pathogen interactions 5) genomics and proteomics, 6) drugs and resistance, 7) cell wall and surface molecules, 8) diagnosis and treatment, and 9) host response. Speakers and attendees are expected to represent the international community of Candida researchers with both established and new investigators as well as students and trainees present. Many of the speakers, in addition to at least 12 graduate students and postdoctoral associates, will be selected from abstracts. NIH through various institutes and programs has generously supported many of the American presenters and attendees of this conference, as well as the previous two conferences and it is hoped that NIH will join ASM and private sources in providing financial assistance for this upcoming 7th Conference in 2004.
描述(由申请人提供):白色念珠菌是一种定植于皮肤和粘膜表面的共生菌。它也是这些表面机会性疾病以及内部传播疾病的媒介。虽然皮肤和粘膜表面的感染可能是导致严重发病的一个原因,并且每年影响数百万美国人,但它们并不像传播疾病那样危及生命。 20 世纪 80 年代中期,越来越多的研究人员被疾病发病机制的研究所吸引。为了满足该群体之间交流思想的需要,第一届 ASM 念珠菌和念珠菌病会议于 1987 年举行,出席人数约为 115 人。从那时起,不仅研究人员的数量增加了,而且疾病患者的数量也增加了。不幸的是,口腔粘膜疾病是艾滋病几乎普遍的并发症,念珠菌现已成为医院血流感染的第四大原因。近年来,出现了唑类耐药菌株,并且非白色念珠菌分离株的频率增加,特别是那些本身具有耐药性的菌株。 该会议每三年举办一次,是从事念珠菌感染生物学、流行病学和发病机制研究的研究人员的首要论坛。然而,在2002年举行的第六次会议上,绝大多数人投票决定将会议安排为两年一次。因此,第七届会议将于 2004 年 3 月 24 日至 28 日在德克萨斯州奥斯汀凯悦酒店举行。第七届会议的目标是继续提供论坛来展示最先进的研究成果,并让研究人员非正式地会面和讨论他们的工作。第七届会议预计将有300-400人参加,展示150-200张海报。口头和/或海报会议将涵盖的主题包括:1)交配和遗传学,2)流行病学和群体研究,3)信号传导和形态发生,4)生物膜和病原体相互作用5)基因组学和蛋白质组学,6)药物和耐药性,7)细胞壁和表面分子,8)诊断和治疗,以及9)宿主反应。演讲者和与会者将代表国际念珠菌研究人员群体,包括现有的和新的研究人员以及学生和实习生。除了至少 12 名研究生和博士后之外,许多演讲者也将从摘要中选出。 NIH 通过各种机构和项目慷慨地支持了本次会议以及前两次会议的许多美国演讲者和与会者,并希望 NIH 能够与 ASM 和私人资源一起为即将于 2004 年举行的第七届会议提供财政援助。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Welda LaJean CHAFFIN其他文献

Welda LaJean CHAFFIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Welda LaJean CHAFFIN', 18)}}的其他基金

Candida albicans-specific mucosal CD4+ T cell clones
白色念珠菌特异性粘膜 CD4 T 细胞克隆
  • 批准号:
    6655419
  • 财政年份:
    2003
  • 资助金额:
    $ 1万
  • 项目类别:
A proteomics approach to Candida albicans biofilm
白色念珠菌生物膜的蛋白质组学方法
  • 批准号:
    6782705
  • 财政年份:
    2003
  • 资助金额:
    $ 1万
  • 项目类别:
A proteomics approach to Candida albicans biofilm
白色念珠菌生物膜的蛋白质组学方法
  • 批准号:
    6906516
  • 财政年份:
    2003
  • 资助金额:
    $ 1万
  • 项目类别:
Candida albicans-specific mucosal CD4+ T cell clones
白色念珠菌特异性粘膜 CD4 T 细胞克隆
  • 批准号:
    6785445
  • 财政年份:
    2003
  • 资助金额:
    $ 1万
  • 项目类别:
A proteomics approach to Candida albicans biofilm
白色念珠菌生物膜的蛋白质组学方法
  • 批准号:
    6696099
  • 财政年份:
    2003
  • 资助金额:
    $ 1万
  • 项目类别:
6th ASM Conference on Candida and Candidiasis
第六届 ASM 念珠菌和念珠菌病会议
  • 批准号:
    6459227
  • 财政年份:
    2002
  • 资助金额:
    $ 1万
  • 项目类别:
Candida albicans oral biofilm
白色念珠菌口腔生物膜
  • 批准号:
    6409089
  • 财政年份:
    2001
  • 资助金额:
    $ 1万
  • 项目类别:
Candida albicans oral biofilm
白色念珠菌口腔生物膜
  • 批准号:
    6773205
  • 财政年份:
    2001
  • 资助金额:
    $ 1万
  • 项目类别:
Candida albicans oral biofilm
白色念珠菌口腔生物膜
  • 批准号:
    6652571
  • 财政年份:
    2001
  • 资助金额:
    $ 1万
  • 项目类别:
Candida albicans oral biofilm
白色念珠菌口腔生物膜
  • 批准号:
    6524140
  • 财政年份:
    2001
  • 资助金额:
    $ 1万
  • 项目类别:

相似海外基金

Candida and Candidiasis Conference 2023
2023 年念珠菌和念珠菌病会议
  • 批准号:
    10682982
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
Functional and transcriptome analyses of protein kinases in Candida glabrata antifungal drug resistance
光滑念珠菌抗真菌药物耐药性中蛋白激酶的功能和转录组分析
  • 批准号:
    10643423
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
Targeting the CCR6-CCL20 pathway for treatment of psoriatic joint and entheseal inflammation
靶向 CCR6-CCL20 通路治疗银屑病关节和附着点炎症
  • 批准号:
    10699251
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
Functional analysis of the signaling adaptor protein during oral candidiasis
口腔念珠菌病期间信号转接蛋白的功能分析
  • 批准号:
    23H03076
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Systematic Genetic Analysis of C. albicans CNS Infection
白色念珠菌中枢神经系统感染的系统遗传分析
  • 批准号:
    10666122
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
Statistical and high-throughput models of enhancer function and evolution
增强子功能和进化的统计和高通量模型
  • 批准号:
    10846272
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
Antifungal discovery from previously uncultivated bacteria
从以前未培养的细菌中发现抗真菌药物
  • 批准号:
    10693593
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
Candida albicans Sap6 dysregulates host epithelial protease-antiprotease expression
白色念珠菌 Sap6 失调宿主上皮蛋白酶-抗蛋白酶表达
  • 批准号:
    10739848
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
Antifungals targeting pantothenate phosphorylation
靶向泛酸磷酸化的抗真菌药
  • 批准号:
    10696567
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
In vivo Monitoring of Neutrophil Function in Patients after Stem Cell Transplant
干细胞移植后患者中性粒细胞功能的体内监测
  • 批准号:
    10679553
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了